MIRM
MIRM
NASDAQ · Biotechnology

Mirum Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$92.00
+0.17 (+0.19%)
As of Sep 21, 8:35 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -27.5% upside
Low Target $36.90
Average Target $66.73
High Target $76.87
Current Price $92.00
Current
$92.00
Target
$66.73
$36.90 $66.73 avg $76.87
Scenario Analysis
Bear Case
$36.90
-59.9%
Low target
Base Case
$66.73
-27.5%
Avg target
Bull Case
$76.87
+-16.4%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$130.00
-29.2% from high
52-Week Low
$63.23
+45.5% from low
50-Day SMA
$87.61
+5.0% vs SMA
200-Day SMA
$68.12
+35.1% vs SMA
RSI (14)
56.6
Neutral
Target vs 52W High
$66.73
-48.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.7%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -51.4%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +139.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.3%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.3%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -13.8%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -61.5%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -41.0%